Dr. Reddy's Laboratories Limited annual gross profit for fiscal 2026 was $177.3 billion, a decrease of 6.9% from $190.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Gross Profit (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Gross Profit | $177.3B | $190.4B | $163.6B | $139.3B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Gross Profit (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit | $43.0B | $46.8B | $48.1B | $48.6B | $56.6B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More RDY metrics: Revenue · Operating Income · Net Income · EPS · Free Cash Flow
All RDY financial statements → Interactive RDY charts →
About TickerBase · Data methodology & sources